How To Conduct A Cancer Research Programme In Spain
|
|
- Doreen Austin
- 3 years ago
- Views:
Transcription
1 1 st Meeting Epidemiology and Cancer Prevention Program RTICC Red Temática de Investigación Cooperativa en Cáncer Barcelona, 1 de marzo del 2013
2 Programa reunión 10h. Introducción de la reunión. JM Borràs 10h 15 Objetivos del Programa de epidemiología y prevención del cáncer. JM Borràs 10h45 Aspectos organizativos y de financiación. Web de la RTICC. Calendario de evaluación por parte del ISCIII. MA Moreno 11h30 Café 11h45 Presentaciones de los grupos (modera CA González): Cada grupo conformado presentará brevemente sus objetivos de investigación, composición y proyectos inmediatos de colaboración en los programas de la RTICC (incluyendo otras redes y CIBERs). Cada grupo tiene 10 como máximo. 13h15 Calendario de actividades para el h30 Conclusiones 13h45 Comida (se servirá en la misma sala)
3 Grupos programa Epidemiología Cancer prevention and control research (IP JM Borras) Nutrition, environment genetic susceptibility and cancer (IP CA Gonzalez) Genetic and molecular epidemiology (IP N Malats) Infections and cancer (IP FX Bosch) Lung cancer prevention (IP J Zulueta) Genetic susceptibility to cancer (IP C Lazaro) Mechanisms of disease (IP P Real) Translational oncology group (IP JC Lacal) Lung cancer biomarkers (L Montuenga) Gastrointestinal cancer (IP G Capella)
4 Work plan WP1: Descriptive epidemiology: Led by Rafael Peris (Group PI JM Borras). Specific activities planned with deliverables together with the Group of FX Bosch, N Malats and CA Gonzalez: To assess trends in cancer incidence in Spain using different statistical Bayesian models, assessing different demographic hypothesis To estimate incidence and mortality based on partial data from cancer registries To analyse survival of childhood cancer in Spain by volume of hospitals To validate incidence data on sarcoma and their subtypes in population cancer registries To analyse Incidence of cancer in Spanish AIDS patients after the introduction of HAART To analyse the incidence of bladder cancer according to the new WHO classification; incidence and survival of GIST tumours and their mutational profiles; and to estimate overdiagnosis of prostate cancer associated with PSA test
5 Work plan WP2: Genetic and Molecular epidemiology: Led by Nuria Malats in cooperation with the groups led by C Lazaro, Ca Gonzalez, FX Real, JC Lacal and L Montuenga: To promote the research conducted by the participating groups through the establishment of a network of national and international researchers/groups of reference in genetic and molecular epidemiology; To train on methodological/statistical aspects for genetic and molecular risk as well as prognostic and predictive factors by sharing expertise and results from the participating groups; To advice on the available technological platforms for omics data determination and analysis and integration in epidemiological studies.
6 Work plan WP3. Infections and cancer: Led by FX Bosch with the contributions of the groups led by Ca Gonzalez and JM Borras To describe the HPV type distribution in cancers of the vulva vagina penile anal and oropharyngeal in Spain and comparisons with the international distributions. The project interacts with pathology departments in Spain pertaining to the RETIC network To assess follow up and prognostic value of HPV DNA in oral cavity and oropharyngeal cancers international collaboration in a EU granted project To create a reference laboratory for HPV infections and cancer To assess the virulence factors of H. pylori as prognostic markers of gastric cancer risk in pre-neoplasic lesions To analyse cost effectiveness analysis of HPV screening and vaccination in Spain
7 Work plan WP4: Lifestyle and environmental factors: Led by CA Gonzalez with the groups led by FX Bosch, JM Borras, L Montuenga, N Malats, JC Lacal and FX Bosch To promote and carryout collaborative research projects among groups participating in the Programme, regarding life-style factors (such as smoking, diet, alcohol and physical exercise) and environmental risk factors for cancer in relation to cervical cancer, oesophageal and gastric cancer, pancreas and bladder cancer To promote and carryout collaborative research projects among groups participating in the Programme in relation with the development and use of biomarkers of exposure to life style and environmental risk factors. In relation mainly to gastric cancer, pancreas and bladder cancer, and cancer of the ovary and endometrium.
8 Work plan WP5. Cancer prevention and control: led by JM Borras with the groups led by J Zulueta, FX Bosch, CA Gonzalez, G Capella, C Lazaro and L Montuenga To analyse the cost effective analysis for different screening strategies for patient with hereditary cancer syndromes, with special interest in the Lynch syndrome To assess the feasibility of lung cancer screening in Spain To analyse the patterns of care in regions of Spain for sarcoma, lung cancer, rectal cancer and breast cancer. Comparison with evidence based clinical guidelines To evaluate the impact of the changes in smoking laws on second hand smoking: assessment of their consequences in prevention of smoking related tumors To analyse the adherence to oral chemotherapy and hormone treatments in breast, rectal, kidney and GIST in a multihospital cohort of patients To assess the effectiveness of weight lost and physical activity in the reduction of recurrences of breast cancer.
9 Organization WP1: Descriptive epidemiology: Led by Rafael Peris (Group PI JM Borras) and other members from this group as well as Dr Bosch group. WP2: Genetic and molecular epidemiology: Led by Nuria Malalts and other groups involved are CA Gonzalez, FX Real, JC Lacal, L Montuenga, G Capellà and C Lazaro. WP3. Infections and cancer: Led by FX Bosch and other groups involved are JM Borras and CA Gonzalez WP4: Lifestyle and environmental factors: Leader will be CA Gonzalez and with the collaboration of other groups such as N Malats, FX Bosch, L Montuenga. WP5. Cancer prevention and control: leader will be JM Borras with the collaboration of J Zulueta, C Lazaro, FX Bosch and CA Gonzalez. Management structure: WP leaders + IPs. Annual review
10 Evaluation Annual review by management structure Actividades cooperativas: Otros grupos RTICC del Programa Epidemiología Otros grupos otros programas RTICC Otras Redes y CIBERs Como mínimo un articulo internacional anual relacionado con los WPs
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008 David R. Risser, M.P.H., Ph.D. David.Risser@dshs.state.tx.us Epidemiologist Cancer Epidemiology and Surveillance Branch
More informationDefending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing
Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing OTHER CANCERS November 2013 Bruce T. Bishop Nancy E. Leary Willcox & Savage 440
More informationNo. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9636/08 SAN 87 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY,
More informationNumber. Source: Vital Records, M CDPH
Epidemiology of Cancer in Department of Public Health Revised April 212 Introduction The general public is very concerned about cancer in the community. Many residents believe that cancer rates are high
More informationCancer in Ireland 2013: Annual report of the National Cancer Registry
Cancer in 2013: Annual report of the National Cancer Registry ABBREVIATIONS Acronyms 95% CI 95% confidence interval APC Annual percentage change ASR Age standardised rate (European standard population)
More informationAccess to hormone receptor testing and other basic diagnostic pathology services in Colombia
Access to hormone receptor testing and other basic diagnostic pathology services in Colombia Dr Fernando Perry Clínica de seno y tejidos blandos Instituto Nacional de Cancerología de Colombia Breast cancer
More informationLung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
More informationCancer Screening and Early Detection Guidelines
Cancer Screening and Early Detection Guidelines Guillermo Tortolero Luna, MD, PhD Director Cancer Control and Population Sciences Program University of Puerto Rico Comprehensive Cancer Center ASPPR Clinical
More informationAlaska Comprehensive Cancer Control Plan 2011-15
Alaska Comprehensive Cancer Control Plan 2011-15 Alaska Comprehensive Cancer Plan 2011-2015 STATE of ALASKA Department of Health and Social Services ALASKA Comprehensive Cancer Partnership Prevention Promotion
More informationEarly Detection Research Network: Validation Infrastructure. Jo Ann Rinaudo, Ph.D. Division of Cancer Prevention
Early Detection Research Network: Validation Infrastructure Jo Ann Rinaudo, Ph.D. Division of Cancer Prevention 15 October 2015 Mission The NCI Early Detection Research Network s (EDRN) mission is to implement
More informationAlabama Cancer Facts & Figures 2011
Alabama Cancer Facts & Figures 2011 1.800.227.2345 cancer.org Have questions about cancer? Cancer information specialists are available 24 hours a day, 7 days a week. Call the American Cancer Society at
More informationCANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer
MEDIA FACTSHEET CANCER EXPLAINED What is cancer? Cancer is a disease which occurs when changes in a group of normal cells within the body lead to uncontrolled growth causing a lump called a tumour; this
More informationExamples of good screening tests include: mammography for breast cancer screening and Pap smears for cervical cancer screening.
CANCER SCREENING Dr. Tracy Sexton (updated July 2010) What is screening? Screening is the identification of asymptomatic disease or risk factors by history taking, physical examination, laboratory tests
More informationBurden of Cancer Mississippi. Mississippi State Department of Health
Burden of Cancer State Department of Health Cancer in : An Overview What is Cancer? Cancer is a large group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread
More informationElectronic health records to study population health: opportunities and challenges
Electronic health records to study population health: opportunities and challenges Caroline A. Thompson, PhD, MPH Assistant Professor of Epidemiology San Diego State University Caroline.Thompson@mail.sdsu.edu
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationQ&A on Monographs Volume 116: Coffee, maté, and very hot beverages
Questions about the Monographs 1. What does the IARC Monographs Programme do? The Monographs Programme identifies and evaluates causes of cancer in humans based on the publically available scientific evidence.
More informationTable 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations
North America Canada Canadian 1951 Schmidt & Popham (1981) 1951 70 9 889 alcoholic men, aged 15 years, admitted to the clinical service of the Addiction Research Foundation of Ontario between Death records
More informationTemario- speakers. Management of the axilla in local and / or regional recurrence Manejo de la axila en la recurrencia local y / regional.
16.08.11 Henry Kuerer MD, PhD, FACS Director Breast SurgicalOncology University of Texas MD Anderson Cancer Center. Houston, TX Re-excision in local recurrence after conservative therapy Retumorectomía
More informationBRAIN TUMOUR RESEARCH FUNDING FLOWS
BRAIN TUMOUR RESEARCH FUNDING FLOWS Ellen Harries, Iona Joy v London, April 2013 (updated) CONTENTS 1 Research brief and headline findings 2 Research funding for cancer 3 Brain tumour funding compared
More informationFulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
More informationNEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA) Merat Esfahani, MD Medical Oncologist, Hematologist Cancer Liaison Physician SwedishAmerican Regional Cancer Center
More informationChapter I Overview Chapter Contents
Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality
More informationOne out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3
1. What is cancer? 2. What causes cancer?. What causes cancer? 3. Can cancer be prevented? The Facts One out of every two men and one out of every three women will have some type of cancer at some point
More informationSection 8» Incidence, Mortality, Survival and Prevalence
Section 8» Incidence, Mortality, Survival and Prevalence 8.1. Description of Statistics Reported This section focuses on the regional distribution of cancer with data derived from the BC Cancer Registry
More informationTHINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER. Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114
THINGS TO BE AWARE OF ABOUT PROSTATE AND LUNG CANCER Lawrence Lackey Jr., M.D. Internal Medicine 6001 W. Outer Dr. Ste 114 WHAT IS CANCER? The body is made up of hundreds of millions of living cells. Normal
More informationCervical cancer is the second most common cancer among South African women
Cervical cancer is the second most common cancer among South African women *SA Statistics as per National Cancer Registry (NCR) 2007 What is cervical cancer? Cervical cancer is a type of cancer that occurs
More informationTHE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
More informationNuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
More informationDiagnosis and Treatment of Common Oral Lesions Causing Pain
Diagnosis and Treatment of Common Oral Lesions Causing Pain John D. McDowell, DDS, MS University of Colorado School of Dentistry Chair, Oral Diagnosis, Medicine and Radiology Director, Oral Medicine and
More informationThe effect of the introduction of ICD-10 on cancer mortality trends in England and Wales
The effect of the introduction of ICD-10 on cancer mortality trends in Anita Brock, Clare Griffiths and Cleo Rooney, Offi ce for INTRODUCTION From January 2001 deaths in have been coded to the Tenth Revision
More informationA23: Oncologic Disease- Tumor Markers
A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of
More informationEvidence-Based Practice for Public Health Identified Knowledge Domains of Public Health
1 Biostatistics Statistical Methods & Theory Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health General Public Health Epidemiology Risk Assessment Population-Based
More informationJESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President
Breast Cancer Epidemiology i in China JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Chinese Academy of Medical Sciences Peking Union Medical College Medical Center
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationProgress and Prospects in Ovarian Cancer Screening and Prevention
Progress and Prospects in Ovarian Cancer Screening and Prevention Rebecca Stone, MD MS Assistant Professor Kelly Gynecologic Oncology Service The Johns Hopkins Hospital 1 No Disclosures 4/12/2016 2 Ovarian
More informationCancer Facts & Figures for African Americans 2013-2014
Cancer Facts & Figures for African Americans 213-214 Contents Cancer Statistics 1 Selected Cancers 1 Cancer Prevention & Early Detection 14 Screening Guidelines for the Early Detection of Cancer in Average-risk
More informationCancer screening: cost-effectiveness. Endoscopic polypectomy: : CRC mortality. Endoscopic polypectomy: : CRC incidence
Cribado del cáncer (colorrectal): las pruebas de detección precoz salvan vidas Dr. Antoni Castells Servicio de Gastroenterología Hospital Clínic nic,, Barcelona (castells@clinic.cat) Conditions for a population-based
More informationOctober is Breast Cancer Awareness Month!
October is Breast Cancer Awareness Month! A STUDY OF CHARACTERISTICS AND MANAGEMENT OF BREAST CANCER IN TAIWAN Eric Kam-Chuan Lau, OMS II a, Jim Yu, OMSII a, Christabel Moy, OMSII a, Jian Ming Chen, MD
More informationPerú 42,284. new cancer cases in 2008 living with cancer 100,000. How many new cancer cases are diagnosed? (INEN, EsSalud, FFAA, Private)
100,000 Perú 42,284 new cancer cases in 2008 living with cancer How many new cancer cases are diagnosed?. 17,000cases (INEN, EsSalud, FFAA, Private) and 85% advanced cases, diagnosis is often too late
More informationDiabetes and Cancer. Gentofte, Denmark http://bendixcarstensen.com. ASCO, 12th Anuual Meeting Chicago, June 2012 1/ 16
Diabetes and Cancer Bendix Carstensen Steno Diabetes Center Gentofte, Denmark http://bendixcarstensen.com ASCO, 12th Anuual Meeting Chicago, June 2012 1/ 16 Conflicts of interest Employee of Steno Diabetes
More informationHow To Prepare A Lung Cancer Screening Course
Lung Cancer Screening Course 2015 Friday, May 8th, 2015 Languages: Spanish and English with simultaneous translation 32 International Conference on Lung Cancer Screening Saturday and Sunday, May 9-10,
More informationKINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY. Always Here When You Need Us
KINGS COUNTY HOSPITAL CENTER EXECUTIVE SUMMARY Always Here When You Need Us Kings County Hospital Center Cancer Care Program ANNUAL REPORT 2013: EXECUTIVE SUMMARY The Kings County Hospital Center Cancer
More informationPROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
More informationNOVEL PLATFORMS FOR CANCER DIAGNOSIS
NOVEL PLATFORMS FOR CANCER DIAGNOSIS Luca Beneduce, Ph.D. Founded in 2001 and headquartered in Venice (Italy) Xeptagen is a privately held biotech company funded by venture capital. Xeptagen s mission
More informationBlood-Based Cancer Diagnostics
The Biotechnology Education Company Blood-Based Cancer Diagnostics EDVO-Kit 141 Store entire experiment at room temperature. EXPERIMENT OBJECTIVE: The objective of this experiment is to learn and understand
More informationMonitoring Clinical Stage to Improve Care
Monitoring Clinical Stage to Improve Care Stephen Dreyer, MD, FACS Cancer Liaison State Chair Nebraska Fremont, NE M. Asa Carter, CTR Manager, Accreditation and Standards American College of Surgeons Chicago,
More informationChemicals, Cancer, and You
Chemicals, Cancer, and You There are many risk factors for cancer: age, family history, viruses and bacteria, lifestyle (behaviors), and contact with (touching, eating, drinking, or breathing) harmful
More informationC a nc e r C e nter. Annual Registry Report
C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases
More informationGuide to Understanding Breast Cancer
An estimated 220,000 women in the United States are diagnosed with breast cancer each year, and one in eight will be diagnosed during their lifetime. While breast cancer is a serious disease, most patients
More informationCancer in North-East Regions of India
North-East Regions of India Avery high incidence of cancers of all sites in general and tobacco and pesticiderelated cancers in particular has been reported in North-East region of India. However, the
More informationVII Programa marco de Euratom Programa de trabajo 2013
VII Programa marco de Euratom Programa de trabajo 2013 E. González (CIEMAT) National Contact Point for EURATOM Fission (Nuclear Fission, Safety and Radiation Protection) Sede central del CSIC 12 de septiembre
More informationpatient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations MARCH 2015 BRCA1 and BRCA2 Mutations Cancer is a complex disease thought to be caused by several different factors. A few types of cancer
More informationGenetics and Breast Cancer. Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service
Genetics and Breast Cancer Elly Lynch, Senior Genetic Counsellor Manager, Austin Health Clinical Genetics Service Overview Background/Our Team What is the difference between sporadic/familial cancer? How
More informationScreening for Prostate Cancer
Screening for Prostate Cancer Review against programme appraisal criteria for the UK National Screening Committee (UK NSC) Version 1: This document summarises the work of ScHARR 1 2 and places it against
More informationAre you worried about prostate cancer? 1
Are you worried about prostate cancer? 1 Are you worried about prostate cancer? This information is from the leaflet Are you worried about prostate cancer? You may find the full leaflet helpful. We can
More informationSurvivorship Care Plans Guides for Living After Cancer Treatment
Survivorship Care Plans Guides for Living After Cancer Treatment Institute of Medicine Report 2005 Recommendations for meeting needs of cancer survivors Implement survivorship care plan Build bridges
More information- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa
- Slide Seminar - Endocrine pathology in non-endocrine organs Case 11 Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa Dept. of Pathology, Multimedica, Milan, Italy Dept. of Surgical and Morphological
More informationHospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University
Hospital-Based Tumor Registry Srinagarind Hospital, Khon Kaen University Statistical Report 2012 Cancer Unit, Faculty of Medicine Khon Kaen University Khon Kaen, Thailand Tel & Fax:+66(43)-202485 E-mail:
More informationSingapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013. National Registry of Diseases Office (NRDO)
Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013 National Registry of Diseases Office (NRDO) Released November 3, 2014 Acknowledgement This report was
More informationInvestigación en España sobre desigualdades en la incidencia, mortalidad, prevención y atención del cáncer.
Investigación en España sobre desigualdades en la incidencia, mortalidad, prevención y atención del cáncer. Estudio bibliométrico y de revisión de la literatura. The state of research into inequalities
More informationOvarian cancer. A guide for journalists on ovarian cancer and its treatment
Ovarian cancer A guide for journalists on ovarian cancer and its treatment Contents Contents 2 3 Section 1: Ovarian Cancer 4 i. Types of ovarian cancer 4 ii. Causes and risk factors 5 iii. Symptoms and
More informationCANCER INCIDENCE RATES IN NORTHEASTERN MINNESOTA. MCSS Epidemiology Report 99:2. September 1999
CANCER INCIDENCE RATES IN NORTHEASTERN MINNESOTA MCSS Epidemiology Report 99: September 999 Minnesota Cancer Surveillance System Chronic Disease And Environmental Epidemiology Section Minnesota Department
More informationSix Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data
Six Degrees of Separation No More: Using Data Linkages to Improve the Quality of Cancer Registry and Study Data Prepared for the 138th Annual Meeting of the American Public Health Association Denver, CO
More informationRanking de Universidades de Grupo of Eight (Go8)
En consecuencia con el objetivo del programa Becas Chile el cual busca a través de la excelencia de las instituciones y programas académicos de destino cerciorar que los becarios estudien en las mejores
More informationConvocatorias 7ª y 8ª. Innovative Medicines Initiative (IMI2)
The Strategical Conference of EU Taiwan ICT Technical Cooperation Reunión Puntos de Contacto en CCAA Madrid, 25 de Enero de 2016 Convocatorias 7ª y 8ª. Innovative Medicines Initiative (IMI2) Juan E. Riese
More informationOverview of study designs
Overview of study designs In epidemiology, measuring the occurrence of disease or other healthrelated events in a population is only a beginning. Epidemiologists are also interested in assessing whether
More informationHorizon 2020 Y emprendedores en la red
Horizon 2020 Y emprendedores en la red 29 November 2011 Oportunidad para el ABI Horizon es el nuevo programa de la UE para la investigación y la innovación con llamadas desde el 2013 EL ABi debe empezar
More informationScreenWise. Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015
ScreenWise Breast, Cervical, and Hereditary Cancer Screenings OCTOBER 28, 2015 ScreenWise Three programs working together to bring quality screening services to Oregon residents Why we all do this work
More informationAdvancing Health Economics, Services, Policy and Ethics. Reka Pataky, MSc ARCC Conference May 25, 2015
Advancing Health Economics, Services, Policy and Ethics Reka Pataky, MSc ARCC Conference May 25, 2015 Acknowledgements: Ontario Team: Dr. Murray Krahn (PI) Dr. Claire de Oliveira Karen Bremner Dr. Kelvin
More informationBiomedical Engineering for Global Health. Lecture Thirteen
Biomedical Engineering for Global Health Lecture Thirteen Outline The burden of cancer How does cancer develop? Why is early detection so important? Strategies for early detection Example cancers/technologies
More informationFacts & Figures 2nd Edition. Estimated Number of New Cancer Cases by World Area, 2008* Worldwide* 12,667,500
Global Cancer Facts & Figures 2nd Edition Estimated Number of New Cancer Cases by World Area, 2008* 15 14 9 17 16 12 10 3 13 7 6 5 11 20 2 1 19 8 21 4 18 Worldwide* 12,667,500 1 Eastern Africa (221,100)
More informationAnalysis of Population Cancer Risk Factors in National Information System SVOD
Analysis of Population Cancer Risk Factors in National Information System SVOD Mužík J. 1, Dušek L. 1,2, Pavliš P. 1, Koptíková J. 1, Žaloudík J. 3, Vyzula R. 3 Abstract Human risk assessment requires
More informationFAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.
INSIDE TRACK CONFERENCE ESO, CNIO AND NRCO CONFERENCE ON FAMILIAL CANCER 19-20 May 2016 Madrid, Spain Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. Vasen, NL FOREWORD The ESO, CNIO and NRCO Conference
More informationEpi procolon The Blood Test for Colorectal Cancer Screening
Epi procolon The Blood Test for Colorectal Cancer Screening Epi procolon is an approved blood test for colorectal cancer screening. The US Preventive Services Task Force, the American Cancer Society and
More informationTips for surviving the analysis of survival data. Philip Twumasi-Ankrah, PhD
Tips for surviving the analysis of survival data Philip Twumasi-Ankrah, PhD Big picture In medical research and many other areas of research, we often confront continuous, ordinal or dichotomous outcomes
More informationProstate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
More informationCancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.
Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific
More informationMutations: 2 general ways to alter DNA. Mutations. What is a mutation? Mutations are rare. Changes in a single DNA base. Change a single DNA base
Mutations Mutations: 2 general ways to alter DNA Change a single DNA base Or entire sections of DNA can move from one place to another What is a mutation? Any change in the nucleotide sequence of DNA Here
More informationRobert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
More informationCancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
More informationPancreatic Cancer. The Killer that must be discovered early. Dr Alfred Kow Wei Chieh
Pancreatic Cancer The Killer that must be discovered early 27 th June 2015 Dr Alfred Kow Wei Chieh Consultant Department of Surgery Division of HPB Surgery & Liver Transplantation & Assistant Dean (Education)
More informationFoundations of Oncology Nursing Practice
Foundations of Oncology Nursing Practice Course Syllabus Course Lead:, RN, MN, BScN, CON(C) Associate Faculty:, RN, CON(C) Last updated January 27, 2011 Course Description: This online course will introduce
More informationKentucky Lung Cancer Research Program. 2010 Strategic Plan Update
Kentucky Lung Cancer Research Program 2010 Strategic Plan Update Approved by the KLCR Program Governance Board August 12, 2009 KLCR Program Strategic Plan Table of Contents Introduction... 3 GOAL 1: Investigator-Initiated
More informationCancer Screening. Robert L. Robinson, MD, MS. Ambulatory Conference SIU School of Medicine Department of Internal Medicine.
Cancer Screening Robert L. Robinson, MD, MS Ambulatory Conference SIU School of Medicine Department of Internal Medicine March 13, 2003 Why screen for cancer? Early diagnosis often has a favorable prognosis
More informationDELRAY MEDICAL CENTER. Cancer Program Annual Report
DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions
More informationFecha: 04/12/2010. New standard treatment for breast cancer at early stages established
New standard treatment for breast cancer at early stages established London December 04, 2010 12:01:13 AM IST Spanish Oncology has established a new standard treatment for breast cancer at early stages,
More informationParticipate in Cancer Screening
Key #3 Participate in Cancer Screening What is Cancer? The National Cancer Institute defines cancer as A term for diseases in which abnormal cells divide without control and can invade nearby tissues.
More informationWhat is HPV? Low-risk HPV types. High-risk HPV types
HPV and Cancer What is HPV? HPV is short for human papilloma (PAP-uh-LO-muh) virus. HPVs are a large group of related viruses. Each HPV virus in the group is given a number, which is called an HPV type.
More informationHow To Know If You Have Cancer At Mercy Regional Medical Center
MERCY REGIONAL CANCER CENTER 2012 CANCER PROGRAM ANNUAL REPORT Using 2011 Data Mercy Regional Cancer Center When you have cancer, you might think first of treatments chemotherapy and radiation. You want
More informationCervical Cancer. What you should know. making cancer less frightening by enlightening
Cervical Cancer What you should know making cancer less frightening by enlightening cervical cancer the facts Around 325 women are diagnosed with cervical cancer in Ireland each year It is the most common
More informationBETTER CANCER CARE, AN ACTION PLAN
, AN ACTION PLAN , AN ACTION PLAN The Scottish Government, Edinburgh 2008 Crown copyright 2008 ISBN: 978-0-7559-5857-3 The Scottish Government St Andrew s House Edinburgh EH1 3DG Produced for the Scottish
More informationCurriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine
Curriculum Vitae Harvard Medical School/ Harvard School of Dental Medicine Date Prepared: November 16, 2009 Name: Zafira Castaño Corsino, Ph.D. Work Phone: (34) 659306730 Work Email: Place of Birth: zcastan@hotmail.com
More informationBristol Hospital Cancer Care Center 2015 Annual Report
Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the
More informationTABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
More informationNational Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28)
National Coverage Determination (NCD) for Tumor Antigen by Immunoassay - CA 125 (190.28) Tracking Information Publication Number Manual Section Number 100-3 190.28 Manual Section Title Tumor Antigen by
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationBRCA in Men. Mary B. Daly,M.D.,Ph.D. June 25, 2010
BRCA in Men Mary B. Daly,M.D.,Ph.D. June 25, 2010 BRCA in Men Inheritance patterns of BRCA1/2 Cancer Risks for men with BRCA1/2 mutations Risk management recommendations for men with BRCA1/2 mutations
More informationEarly mortality rate (EMR) in Acute Myeloid Leukemia (AML)
Early mortality rate (EMR) in Acute Myeloid Leukemia (AML) George Yaghmour, MD Hematology Oncology Fellow PGY5 UTHSC/West cancer Center, Memphis, TN May,1st,2015 Off-Label Use Disclosure(s) I do not intend
More informationPREVENTIVE CARE SERVICES Detailed descriptions
PREVENTIVE CARE SERVICES Detailed descriptions How often and what kind of preventive care services you need depends upon your age, gender, health and family history. Not all items on this list are covered
More information